Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
The U.S. Food & Drug Administration releases a list of pre-market approvals granted in April 2014. Read more
Ocular Therapeutix is looking to raise as much as $80 million in a forthcoming initial public offering, the company said today.
Bedford, Mass.-based Ocular Therapeutix said it plans to offer 5 million shares at $14 to $16 apiece, making the IPO worth $70 million to $80 million. Read more
A Covidien shareholder yesterday filed a purported class action lawsuit seeking to block the medical device company’s pending $43 billion merger with Medtronic.
Richard Taxman accuses Covidien, its board of directors and chairman, president & CEO José Almeida of breaching their fiduciary duties in agreeing to the acquisition, which values COV shares at $93.22 apiece. Read more